Evidence map›Paper›PMID 35116699›Full record

ArticleTranslational cancer research2021

Increased

Jiuyang Liu, Yukun He, Chengxin Li, Rui Zhou, Qianqian Yuan, Jinxuan Hou, Gaosong Wu

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Translational cancer research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jiuyang Liu *Department of Breast & Thyroid Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China.
Yukun He *Department of Breast & Thyroid Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China.
Chengxin LiDepartment of Breast & Thyroid Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China.
Rui ZhouDepartment of Breast & Thyroid Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China.
Qianqian YuanDepartment of Breast & Thyroid Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China.
Jinxuan HouDepartment of Breast & Thyroid Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China.
Gaosong WuDepartment of Breast & Thyroid Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China.
Zhongnan Hospital of Wuhan University · CNWuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBreast cancer (BC) has long been a major death threat facing women worldwide. With the development of comprehensive treatment methods, the prognosis of BC was improved but still unsatisfactory. This study was aimed to identify the key genes in BC tumorigenesis and investigate potential prognostic predictors.

methodsDifferential expression genes were analyzed in TCGA BRCA dataset using Genevestigator software. The expression profile of target gene was explored, and the correlations between selected genes with important clinical parameters were evaluated as well. The prognostic values of target genes were also carried out through Kaplan-Meier plotter OncoLnc and BC gene-expression miner.

results

conclusionsTaken together, KIAA0101 could be considered as a diagnostic biomarker or predictor for BC prognosis.

Indexed as

breast cancer (BC)KIAA0101prognosis

Identifiers

PMID35116699
PMCPMC8797655
OpenAlexW3196559972

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.